TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Turk İlaç ve Serum Sanayi A.Ş. is a pharmaceutical company specializing in the production of human medicines. The company operates Turkey's highest-capacity IV parenteral solution (serum) production facility and is a major supplier to the country's public and private hospitals. A pioneer in domestic vaccine manufacturing, it established Turkey's first private vaccine production plant. Its portfolio also includes a range of other pharmaceuticals such as tablets, capsules, ampoules, and vials, all produced in its integrated, GMP-compliant facilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-19 08:47
Regulatory Filings
2025-9 Aylık IMS (IQVIA) resmi verilerinde ürünlerimizin Türkiye Pazarındaki Ku…
Turkish 17.7 KB
2025-11-18 12:36
Regulatory Filings
Emkan Global İle İmzalanan Yetkili Satıcılık Sözleşmesi Hakkında
Turkish 33.8 KB
2025-10-30 16:20
Regulatory Filings
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 1.7 MB
2025-10-30 16:20
Environmental & Social Information
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-10-30 16:19
Quarterly Report
Sorumluluk Beyanı
Turkish 20.4 KB
2025-10-30 16:19
Regulatory Filings
2025 3 dönem Faaliyet Raporu
Turkish 2.1 MB
2025-10-30 16:19
Report Publication Announcement
2025 3 dönem Faaliyet Raporu
English 10.9 KB
2025-10-30 16:18
Quarterly Report
Financial Report
Turkish 1.7 MB
2025-10-30 16:18
Quarterly Report
Financial Report
English 2.5 MB
2025-10-28 17:23
Environmental & Social Information
Sürdürülebilirlik Komitesi Üye Seçimi
Turkish 17.4 KB
2025-10-07 13:01
Regulatory Filings
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-10-07 12:49
Regulatory Filings
DMO İhale Sonucu Hakkında
English 42.6 KB
2025-09-29 14:13
Capital/Financing Update
Finansman Bonosu İtfası Hakkında
English 15.2 KB
2025-09-29 07:01
Capital/Financing Update
Satışın Tamamlanması Hakkında
English 18.2 KB
2025-09-25 14:55
Capital/Financing Update
Borçlanma Aracı İhracı Hakkında
English 17.9 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.